Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-003600-12Phase 4Active
Phase 4, randomised trial of salbutamol in exercise-induced bronchospasm (EIB) and airway morbidity (3 arms), sponsored by Sport Medisch Centrum Papendal. Primary endpoint: Exercise-induced fall in FEV1. Started Aug 2012; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-003600-12.